Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | AQSTAquestive Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $44.55M |
| Revenue, yoy | −22.6% |
| Net income | $83.78M |
| Net income, yoy | −89.8% |
| Net margin | -188.1% |
| Free cash flow | $52.99M |
| FCF margin | -119.0% |
| EPS, diluted | $0.78 |
Add another company.